SCHEMBL29360448

SCHEMBL29360448

CCCOc1cc2ccccc2nc1-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 6/20 0.64
PDE10A Q9Y233 1/20 0.53
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
STAT3 P40763 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GPBAR1 Q8TDU6 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28695684 0.88 TLR8 (0.62) TLR8PDE10AKDM4EALDH1A1GAA
SCHEMBL10641295 0.79 L3MBTL1 (0.61) TLR8PDE10AKDM4EALDH1A1GAA
SCHEMBL31529366 0.79 L3MBTL1 (0.61) TLR8PDE10AKDM4EALDH1A1GAA
SCHEMBL29366598 0.79 PDE10A (0.59) TLR8PDE10AKDM4EMEN1ALDH1A1
SCHEMBL16836411 0.78 TLR8 (1.00) TLR8
Hydrochloric Acid SCHEMBL9847504 0.75 L3MBTL1 (0.60) TLR8PDE10AKDM4EMEN1ALDH1A1
SCHEMBL29207050 0.74 PDE10A (0.54) TLR8PDE10AKDM4EMEN1ALDH1A1
SCHEMBL30060467 0.74 MEN1 (0.61) TLR8KDM4EMEN1ALDH1A1GAA
SCHEMBL4269051 0.74 MEN1 (0.61) TLR8KDM4EMEN1ALDH1A1GAA
SCHEMBL28214645 0.73 PDE10A (0.57) TLR8PDE10AKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121574128-A Pyrimidine-hydroxamic acid compounds and uses thereof 华东理工大学 2026-02-27 CN disclosed
US-12377079-B2 Antibacterial compounds and uses thereof THE CHILDREN'S MEDICAL CENTER CORPORATION 2025-08-05 US disclosed
US-20250092471-A1 METHODS AND REAGENTS FOR DETECTING PIPERAQUINE-RESISTANT PLASMODIUM FALCIPARUM MALARIA INSTITUT PASTEUR (FR) 2025-03-20 US disclosed
CN-119176840-A Phosphorus-containing (meth) acryl composition, method for producing same, flame-retardant resin composition, prepreg, and use thereof 日铁化学材料株式会社 2024-12-24 CN disclosed
US-12168805-B2 Methods and reagents for detecting piperaquine-resistant plasmodium falciparum malaria INSTITUT PASTEUR (FR) 2024-12-17 US disclosed
US-20220023270-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2022-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12377079-B2 Antibacterial compounds and uses thereof CLPP, SPOUT1, MRPL21 TLR8 82/4885PDE10A 2912/4885KDM4E 4451/4885
US-20220023270-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF CLPP, SPOUT1, MRPL21 TLR8 82/4885PDE10A 2912/4885KDM4E 4451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.